This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $742,050
Creatine Monohydrate Relative to Placebo for Treatment of Mood Disorders
CIHR · 2026 · Principal investigator
- $100,000
MIRA for Adaptive CLinical Evaluation in Depression (MIRACLE-D): Design and Evaluation of an AI-Powered Personalized Virtual Assistant for Depression Care
CIHR · 2026 · Co-investigator
- $730,576
The PLATform for INnovative Multicentre trials for comorbid chronic Pain and Depressive disorders (PLATINuM-PD)
CIHR · 2026 · Principal investigator
Creatine Monohydrate Relative to Placebo for Treatment of Mood Disorders
Principal investigators: Courtney, Darren; Husain, Muhammad I; Jones, Brett
Keywords: Adolescents; Adults; Bipolar Affective Disorder; Creatine Monohydrate,; Feasibility Study; Major Depressive Disorder; Randomized Controlled Trial; Supplementation
MIRA for Adaptive CLinical Evaluation in Depression (MIRACLE-D): Design and Evaluation of an AI-Powered Personalized Virtual Assistant for Depression Care
Principal investigators: Bhat, Venkat; Gallson, Dave; Greenshaw, Andrew J; Jetly, Rakesh; Lou, Wen-Yi W; Mulsant, Benoit H; Porter, Ken D; Rockwell, Geoffrey M; Selby, Peter L; Sharma, Divya; Zaiane, Osmar R
Keywords: Agentic Ai; Artificial Intelligence; Conversational Agent; Major Depressive Disorder
The PLATform for INnovative Multicentre trials for comorbid chronic Pain and Depressive disorders (PLATINuM-PD)
Principal investigators: Ladha, Karim; Clarke, Hance A; Goel, Akash; Husain, Muhammad I; Rosenblat, Joshua D; Rosenbloom, Brittany; Voineskos, Daphne; Zrenner, Christoph D
Keywords: Chronic Pain; Depression; Platform Trial
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
Principal investigators: Hahn, Margaret; Agarwal, Sri Mahavir; Kloiber, Stefan M; Mansur, Rodrigo B; Saraf, Gayatri; Taylor, Valerie Hannah
Keywords: Bipolar Disorder; Depression; Insulin Resistance; Metformin; Treatment Resistance
Adjunctive Psilocybin for Treatment Resistant Depression (Ad-Psilo): A Randomized, Active Placebo-Controlled, Phase II Clinical Trial
Principal investigators: Rosenblat, Joshua D; Husain, Muhammad I; Konstantinou, Gerasimos
Keywords: Clinical Trial; Drug Development; Major Depressive Disorder; Mood Disorders; Pharmacotherapy; Psilocybin; Psychedelics; Psychotherapy; Suicide; Treatment Resistant Depression
A Pilot Randomized Clinical Trial of Psilocybin Therapy for Treatment Resistant Late Life Depression.
Principal investigators: Konstantinou, Gerasimos; Blumberger, Daniel M
Keywords: Existential Stress; Loneliness; Psilocybin; Treatment-Resistant Late-Life Depression
Using inflammation to advance precision treatment of refractory depression
Principal investigators: Kittur, Mary E
Keywords: Anti-Inflammatory Treatment; Inflammatory Biomarkers; Precision Psychiatry; Randomized Clinical Trial (Rct); Treatment-Resistant Depression (Trd)
Combining Ketamine with Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals with Treatment Resistant Depression and Borderline Personality Disorder: A Phase II Randomized, Midazolam-Controlled Clinical Trial
Principal investigators: Rosenblat, Joshua D; Burhan, Amer M; McMain, Shelley F
Keywords: Anesthesiology; Borderline Personality Disorder; Clinical Trial; Dialectical Behavioural Therapy; Ketamine; Major Depressive Disorder; Psychotherapy; Suicide; Treatment Resistant Depression
The Epidemiology of and Outcomes Associated with Comorbid Chronic Pain and Depression: Analysis of Canadian Longitudinal Study on Aging (CLSA) data
Principal investigators: Ladha, Karim; Clarke, Hance A
Keywords: Aging; Chronic Pain; Cognitive Decline; Comorbidity; Depression; Epidemiology; Prevalence
The Sustained Mood Improvement with Laughing Gas Exposure (SMILE) Trial
Principal investigators: Ladha, Karim; Husain, Muhammad I; Rosenblat, Joshua D
Keywords: Active Placebo; Depression Remission; Depression Response; Midazolam; Nitrous Oxide; Randomized Controlled Trial; Treatment Efficacy; Treatment-Resistant Depression
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.